HIGHLIGHTS
- who: Sabrina Ritscher and colleagues from the Institute of Legal Medicine, Department of Forensic Toxicology, Hospital, GoetheEditor: Tatsuo Shimosawa, International University have published the Article: Benefit of serum drug monitoring complementing urine analysis to assess adherence to antihypertensive drugs in first-line therapy, in the Journal: PLOS ONE of February/26,/2020
- what: The aim of this study was to evaluate a therapeutic drug monitoring (TDM) method for assessment of adherence based on cut-offs in inpatients and to compare it to an established urine drug screening in outpatients. This study confirms that assessing adherence . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.